Archive - Adith Arun

Onvansertib will not add much value as first line therapy for patients with RAS-mutant metastatic colorectal cancer

Why Cardiff Oncology's July 29, 2025 readout will not be a win

Jul 28 •

Understanding the science behind the gene editing treatment for Baby KJ

A workflow for the rapid development of N-of-1 gene editing treatments

Jul 17 •

What I'm reading this week: 7/7/2025

papers I'm working my way through this week

Jul 8 •

How did X-Rays gain mass adoption?

And what we can learn from this process to understand why cell-free DNA adoption has not skyrocketed yet

Jul 7 •

June 2025

Writing about biology/medicine x AI. And other things I find interesting in medicine

Jun 21 •

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts